CareDx, Inc. (CDNA)
CareDx Market Cap : 981.33M for Feb. 20, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Celldex Therapeutics, Inc. | 1.541B |
| Plus Therapeutics, Inc. | 40.13M |
| Atossa Therapeutics, Inc. | 37.55M |
| Abeona Therapeutics, Inc. | 279.09M |
| Cell Source, Inc. | 38.28M |
Market Cap Related Metrics
| PE Ratio | 16.00 |
| PS Ratio | 2.952 |
| Price to Book Value | 3.154 |
| Price to Free Cash Flow | 29.01 |
| Price | 19.08 |
| Earnings Yield | 6.25% |
| Normalized PE Ratio | 106.24 |